BACKGROUND. The clinicopathologic characteristics of malignant lymphomas vary according to geography. The aim of this study was to determine the clinical characteristics of malignant lymphomas and the relative frequency in the Republic of Korea of lymphomas belonging to the newly described REAL (revised European-American lymphoma) classification categories.
M alignant lymphoma is a diverse group of malignancies containing many different histologic categories. As is already known, the relative frequency of the occurrence of different histologic and immunophenotypic subtypes varies according to geography, and this may be ascribed to genetic and environmental etiologic factors. Compared with Western countries, regions of Asia (including Hong Kong, Japan, and China) have reported higher rates of T-cell lymphoma and lower rates of follicular lymphoma and Hodgkin's disease (HD). 1 In the Republic of Korea, a previous nationwide study 2 that used the Working Formulation demonstrated a similar pattern in the distribution of malignant lymphomas, with a higher rate of T-cell lymphoma. 3 Recent developments in immunologic and molecular genetic techniques provided additional information about malignant lymphoma and assisted in the recognition of new entities and the refinement of previously recognized disease categories. The REAL (revised European-American lymphoma) classification proposed by the International Lymphoma Study Group 4 has provoked criticism of its usefulness in the routine practice of diagnostic pathology and clinical validity. However, it includes several new entities that were not included in previous classifications and has provided common terminology to these entities. In this study, the hematolymphoreticular study group of the Korean Society of Pathologists sought to determine the relative frequency of REAL entities in the Republic of Korea by conducting a nationwide retrospective review of 1548 cases of malignant lymphoma, including HD, according to the REAL classification.
MATERIALS AND METHODS
A total of 1548 cases of malignant lymphoma, including HD, diagnosed at 23 institutes between November 1994 and October 1996 were enrolled in the study. The participating institutes included 21 university hospitals and 1 cancer center, which were large hospitals representative of each local area and evenly distrib-uted across the central, southeastern, and southwestern parts of the Korean peninsula. For convenience of study, these institutes were divided into 5 groups according to geographic area ( Fig. 1 ). In each group, H & E-stained slides and immunohistochemical stains for basic B-and T-cell markers (CD20 and/or MB2, CD3 and/or CD45RO) were histologically evaluated and classified by schema proposed by the International Lymphoma Study Group. 4 The cases showing discordance between more than 30% of participants in each group were reevaluated by a panel of reviewers (J. D. Lee The histologic and clinical results were compared with those of a previous nationwide study reported in 1991, 2 which analyzed the diagnoses of 1165 cases at 21 institutes between 1985 and 1987. Immunophenotypic results were compared with those of a previous study in 1992, 3 which reported the immunophenotypic analysis of 253 cases of non-Hodgkin's lymphoma (NHL).
RESULTS

Incidence of Disease According to Age and Gender
The median age at the onset of disease was 52 years for NHL patients and 41.5 years for HD patients. The peak age of disease was in the 20s for HD and in the 50s for NHL. Bimodal distribution of the age specific incidence rate was not obvious in HD. Compared with that reported in 1991, the age incidence pattern has not changed. The male-to-female ratio was 1.6:1.
Relative Frequency of Hodgkin's Disease and Non-Hodgkin's Lymphoma
Of 1548 cases, there were 1466 cases of NHL (94.7%) and 82 cases of HD (5.3%) ( Table 1 ). This rate was very similar if not identical to that reported in 1991 (94.7% vs. 5.3%).
Immunophenotype of Non-Hodgkin's Lymphoma
Of 1466 cases of non-Hodgkin's lymphoma, 1097 cases (74.8%) were B-lineage and 366 cases (25%) were T-(or putative natural killer [NK])-lineage, including 42 cases (2.9%) of T-lymphoblastic lymphoma ( Table 2 ). In comparison with data reported in 1992, from a study of the immunophenotype of 253 cases of NHL, the proportion of T-lineage lymphoma was markedly decreased. At that time, the T-lineage of lymphoma accounted for 35.2% of malignant lymphomas.
Histologic Types by REAL Classification Non-Hodgkin's lymphoma
Among 1466 cases of NHL, the most common histologic type was diffuse large B-cell lymphoma, followed by extranodal marginal zone B-cell lymphoma, peripheral T-cell lymphoma, unspecified type angiocentric lymphoma, and follicle center lymphoma, in decreasing order of frequency (Table 3 ). In comparison with the study in 1991 using the Working Formulation of the National Cancer Institute (Table 4) , there was an increase in follicle center lymphomas from 18 cases (1.6%) to 91 cases (6.2%).
Hodgkin's disease
Of 82 cases of Hodgkin's disease, the most common subtype was mixed cellularity, followed by nodular sclerosis, lymphocyte predominance, and lymphocyte depletion, in decreasing order of frequency (Table 5 ).
In comparison with the data in 1991, there was an increase in nodular sclerosis from 13 cases (23.2%) to 26 cases (31.7%) and a decrease in lymphocyte predominence and lymphocyte depletion.
Sites of Involvement Non-Hodgkin's lymphoma
Information for sites of biopsy was available in 1464 of 1466 cases in the current study and in 911 of 1103 cases in the study conducted in 1991 (Table 6 ). In the current study, 926 cases (63.3%) were classified as extranodal lymphoma and the remainder (538 cases) involved the lymph nodes. The most common extranodal site was the gastrointestinal tract, with the stomach involved in 13.4%, the small intestine in 4.1%, and the large intestine in 3.2% of cases. In comparison with data in 1991, the proportion of extranodal lymphomas was not changed. There was an increase in lymphomas involving the stomach from 70 cases (7.7%) to 196 cases (13.4%) and the orbit from 5 cases (0.5%) to 57 cases (3.9%). Most of these cases were categorized as marginal zone B-cell lymphoma. The frequency of primary central nervous system lymphoma was increased as well. Lymphoma involving Waldeyer's tonsillar ring was decreased from 177 cases (19.4%) to 116 cases (7.9%).
Hodgkin's disease
Of 82 cases, 77 (94%) involved the lymph nodes. Other sites of involvement included the lungs in two cases, the mediastinum in one case, and the spleen in one case.
Histologic Subtypes of NHL According to Site
The distribution of histologic subtypes was different according to the site of involvement (Table 7 ). In the lymph nodes, diffuse large B-cell lymphoma was 
DISCUSSION
The cases included in this study were collected from 23 large institutes covering all geographic regions of the Republic of Korea except the eastern region. Considering the numbers of participating institutes and collected cases, and complete histologic reexamination by participants, the results of this study would be representative of malignant lymphoma in the Republic of Korea, although we admit that there are some weaknesses in the study related to the exclusion of the eastern part of Korea. The data demonstrated that the relative frequency of the different subtypes of malignant lymphomas in the Republic of Korea is distinct from that in Western countries and shares many similarities with other Far East countries. The low relative frequency of HD, which accounts for less than 10% of malignant lymphomas, is a common finding in regions of the Far East, including China, Japan, Taiwan, and Hong Kong. [5] [6] [7] [8] [9] This is in contrast to the high frequency (40 -45% of cases) reported in the U.S. and Europe. Epstein-Barr virus has been detected in 69% of HD cases in the Republic of Korea. 10 Compared with the data reported in 1991, the increase in the relative frequency of nodular sclerosis over time suggests that the patterns of malignant lymphoma occurrence in the Republic of Korea might be gradually changing, probably due to westernization. Alternatively, diagnostic criteria applied in this study might be more refined than that of the study in 1991. The lower rate of follicular lymphoma in the Far East when compared with that in Western countries is well recognized. The relative rate of follicular lymphoma in this study is comparable to that for other countries in the Far East. 1 Compared with the previous study, the increase in the relative frequency of follicle center lymphoma may represent an increase in the true incidence of follicular lymphoma in the Republic of Korea. On the other hand, the follicular lymphoma category in this study contains many cases of partially follicular lymphoma that might have been overlooked as diffuse lymphoma in the previous study. Another explanation for the increased frequency of follicular lymphoma could be that the recent increase in the availability and utilization of early medical care has made it possible to detect follicular lymphoma sooner, while it is in a completely follicular stage. A similar trend in completely follicular lymphoma has been reported for Japan. 11 It is noteworthy that the frequency of NHLs arising in the stomach was increased compared with the previous study in 1991, whereas the relative frequency of lymphomas in the small intestine and colon did not change. Considering that marginal zone B-cell lymphoma accounted for more than 70% of gastric lymphomas but only 30% of intestinal lymphomas, the increased rate of gastric lymphoma may be attributable to the enhanced ability of pathologists to differentiate marginal zone B-cell lymphoma from chronic active gastritis and gastric pseudolymphoma. As in the stomach, a similar increase was found in lymphoma of the orbit. More than 50% of NHLs in this site were marginal zone B-cell lymphomas, most of which were previously diagnosed as pseudolymphomas.
Mantle cell lymphoma is a recently redefined entity. The relative frequency in the Republic of Korea was lower than that of a population-based study in Europe 12 (1.2% vs. 3.7%).
In regard to the frequency of the immunologic subtypes, this study demonstrated that the rate of T-(or putative NK)-cell lymphomas in the Republic of Korea was much less than that of other Far East regions, 7, 8, 11, 13 excluding Hong Kong. 15 This low rate of T-(or putative NK)-cell lymphoma was unexpected. Previous studies from the Republic of Korea in 1992 had reported a high incidence of T-cell lymphoma, accounting for about 35.2% of NHL. 3 However, a similar trend in the decreased rate of T-cell lymphoma has been seen in Japan. Previously, the rate of T-cell lymphoma in human T-cell lymphoma virus (HTLV)-I nonendemic areas of Japan was reported to be 40.1% 7 , but a recent study revealed that 23% of NHLs were T/NK lineage. 16 This rate of T-(or putative NK)-cell lymphoma was comparable to rates in the Western population or slightly higher. The change in the rate of T-(or putative NK)-cell lymphoma over time might represent a true decrease in T-(or putative NK)-lineage lymphoma in the Far East; however, we speculate that previous studies overestimated the rate of T-cell lymphoma due to case selection bias and the small number of cases enrolled in the study.
Of postthymic T-cell lymphomas, HTLV-I-associated adult T-cell lymphoma/leukemia is the rarest in Korea. Until now, only three cases have been report-ed. 17 In healthy individuals, a seroepidemologic study of anti-HTLV-I antibody revealed a low prevalence of 0.25%. 18 As in other Far East countries, Korea has a relatively high rate of angiocentric lymphomas, with more than 70% of them arising in the nose and paranasal sinus. Previous immunohistochemical and molecular genetic analysis in Korea revealed that angiocentric lymphomas arising in these sites were often negative for T-cell receptor gene rearrangement and positive for CD56 and cytoplasmic CD3, suggesting that most Korean angiocentric lymphomas in the nose and paranasal sinus belong to NK lineage. EBV was positive in 63.6% of entire angiocentric lymphomas and in 80% of nasal and paranasal angiocentric lymphomas. 19, 20 A clinical analysis revealed that the rate of extranodal lymphoma exceeded that of lymph node lymphoma (63.3% vs. 36.7%). This rate is much higher than that for the U.S. (26%), Hong Kong (28.5%), Japan (45%), and Taiwan (37.9%), 9, 21 but similar to that of recent Japanese series (60%). 16 Although this study was based on the biopsy materials and lacked complete information on staging, a consistent excess of extranodal lymphoma in the current study and the previous study suggested that extranodal predominance might be one of characteristics of malignant lymphoma in the Republic of Korea. Also notable was that the median age of patients at the time of presentation was younger than in the U.S. (52 years vs. 65 years), 22 which might be attributable to the lower frequency of lymph node type lymphoma, including follicle center lymphoma, that tends to occur in older patients.
In conclusion, the occurrence rates of malignant lymphomas in Korea are distinct from those in Western countries and share many similarities with those in other Far East countries. Compared with other Far East countries, Korea has a higher rate of extranodal lymphoma, rare adult T-cell lymphoma, and a relatively low rate of T-cell lymphomas. There have been changes in the relative rate of follicular lymphoma, subtypes of HD, and gastric and ocular lymphomas over time. These changes are primarily attributable to refined diagnostic criteria of new clinicopathologic entities.
